Vireo Growth (VREOF) Cash & Current Investments (2020 - 2026)

Vireo Growth's (VREOF) quarterly Cash & Current Investments came in at $123.4 million in Q1 2026, up 40.3% year-on-year from $88.0 million in Q1 2025, and little changed quarter-over-quarter from $123.5 million in Q4 2025.

Vireo Growth (VREOF) Cash & Current Investments (2020 - 2026) Analysis & Trends

Vireo Growth has disclosed Cash & Current Investments across 7 years of filings, most recently posting $123.4 million for Q1 2026.

  • Cash & Current Investments for Q1 2026 came in at $123.4 million, up 40.3% year-over-year; the trailing twelve-month figure through Mar 2026 was $123.4 million (up 40.3% YoY), and the FY2025 annual result was $123.5 million, up 31.56% from the prior year.
  • Cash & Current Investments came in at $123.4 million for Q1 2026 at Vireo Growth, roughly flat from $123.5 million in the prior quarter.
  • In the past five years, Cash & Current Investments ranged from a high of $123.5 million in Q4 2025 to a low of $7.3 million in Q3 2024.
  • The 5-year median for Cash & Current Investments is $17.0 million (2022), against an average of $47.1 million.
  • Across the five-year window, Cash & Current Investments sank 78.79% in 2022 and jumped 1528.49% in 2025, its largest moves.
  • Vireo Growth's Cash & Current Investments stood at $15.1 million in 2022, then rose by 18.17% to $17.9 million in 2023, then jumped by 424.36% to $93.9 million in 2024, then soared by 31.56% to $123.5 million in 2025, then fell by 0.08% to $123.4 million in 2026.
  • The last three Cash & Current Investments figures came in at $123.4 million (Q1 2026), $123.5 million (Q4 2025), and $118.6 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 3.74 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 1.94 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 2.15 Bn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn 77.77 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 1.32 Bn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 428.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 511.86 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 750.88 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 498.58 Mn
10 Vireo Growth - - 59.30 Mn 123.40 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 123.40 Mn
Dec 31, 2025 123.50 Mn
Sep 30, 2025 118.55 Mn
Jun 30, 2025 107.19 Mn
Mar 31, 2025 87.95 Mn
Dec 31, 2024 93.87 Mn
Sep 30, 2024 7.28 Mn
Jun 30, 2024 11.23 Mn
Mar 31, 2024 12.60 Mn
Dec 31, 2023 17.90 Mn
Sep 30, 2023 13.30 Mn
Jun 30, 2023 11.35 Mn
Mar 31, 2023 10.35 Mn
Dec 31, 2022 15.15 Mn
Sep 30, 2022 21.84 Mn
Jun 30, 2022 16.97 Mn
Mar 31, 2022 8.60 Mn
Dec 31, 2021 15.16 Mn
Sep 30, 2021 11.78 Mn
Jun 30, 2021 20.83 Mn